# Arbutus Biopharma Corp: Form 8-K, filed Nov 7, 2023

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: 8-K
- Filed: 2023-11-07
- Accepted by EDGAR: Nov 7, 2023, 07:16 ET
- Period: 2023-11-01
- Accession: 0001171843-23-006795
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000117184323006795/f8k_110723.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000117184323006795/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000117184323006795/f8k_110723.htm

Filed Nov 7, 2023.
Source: SEC EDGAR, the filing index for accession 0001171843-23-006795. Last ingested by Listed: Oct 27, 2026, 17:27 ET. No prices; not investment advice.